Chemed (CHE) Competitors

Chemed (NYSE:CHE) and Laboratory Co. of America (NYSE:LH) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, valuation, risk, institutional ownership, analyst recommendations, media sentiment, community ranking, earnings and profitability.

Is CHE or LH a better dividend stock?

Chemed pays an annual dividend of $2.00 per share and has a dividend yield of 0.3%. Laboratory Co. of America pays an annual dividend of $2.88 per share and has a dividend yield of 1.2%. Chemed pays out 10.0% of its earnings in the form of a dividend. Laboratory Co. of America pays out 32.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Chemed has increased its dividend for 16 consecutive years.

Does the media refer more to CHE or LH?

In the previous week, Laboratory Co. of America had 3 more articles in the media than Chemed. MarketBeat recorded 18 mentions for Laboratory Co. of America and 15 mentions for Chemed. Laboratory Co. of America's average media sentiment score of 1.35 beat Chemed's score of 1.19 indicating that Laboratory Co. of America is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Chemed	9 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Laboratory Co. of America	16 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Is CHE or LH more profitable?

Chemed has a net margin of 12.69% compared to Laboratory Co. of America's net margin of 5.73%. Chemed's return on equity of 27.86% beat Laboratory Co. of America's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Chemed	12.69%	27.86%	19.12%
Laboratory Co. of America	5.73%	15.29%	7.01%

Do analysts prefer CHE or LH?

Chemed presently has a consensus price target of $667.00, indicating a potential upside of 10.74%. Laboratory Co. of America has a consensus price target of $268.38, indicating a potential upside of 12.58%. Given Laboratory Co. of America's higher probable upside, analysts plainly believe Laboratory Co. of America is more favorable than Chemed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Chemed	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Laboratory Co. of America	0 Sell rating(s)	3 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.87

Which has more risk & volatility, CHE or LH?

Chemed has a beta of 0.43, indicating that its share price is 57% less volatile than the S&P 500. Comparatively, Laboratory Co. of America has a beta of 1.12, indicating that its share price is 12% more volatile than the S&P 500.

Do insiders & institutionals have more ownership in CHE or LH?

95.8% of Chemed shares are owned by institutional investors. Comparatively, 95.9% of Laboratory Co. of America shares are owned by institutional investors. 3.3% of Chemed shares are owned by insiders. Comparatively, 0.9% of Laboratory Co. of America shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Which has better earnings and valuation, CHE or LH?

Laboratory Co. of America has higher revenue and earnings than Chemed. Laboratory Co. of America is trading at a lower price-to-earnings ratio than Chemed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Chemed	$2.43B	3.63	$272.51M	$19.91	30.25
Laboratory Co. of America	$13.01B	1.53	$746M	$8.82	27.03

Does the MarketBeat Community favor CHE or LH?

Laboratory Co. of America received 289 more outperform votes than Chemed when rated by MarketBeat users. Likewise, 64.03% of users gave Laboratory Co. of America an outperform vote while only 63.50% of users gave Chemed an outperform vote.

Company	Underperform	Outperform
Chemed	Outperform Votes 334 63.50%	Underperform Votes 192 36.50%
Laboratory Co. of America	Outperform Votes 623 64.03%	Underperform Votes 350 35.97%

Summary

Laboratory Co. of America beats Chemed on 12 of the 22 factors compared between the two stocks.